In Singapore, full drug registration involves comprehensive evaluation of a drug’s safety, efficacy, and quality, requiring extensive clinical data. Abridged registration, however, allows for a faster process by relying on prior approvals from recognized regulatory authorities, focusing on essential data to ensure safety and efficacy without duplicating existing evaluations.